NCI | Technology Transfer

METHODS OF ISOLATING T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION

Read more about METHODS OF ISOLATING T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION

China
202411616177.4
Filed on 2024-11-13

ANTI-B-CELL MATURATION ANTIGEN CHIMERIC ANTIGEN RECEPTORS WITH HUMAN DOMAINS

Read more about ANTI-B-CELL MATURATION ANTIGEN CHIMERIC ANTIGEN RECEPTORS WITH HUMAN DOMAINS

Australia
2024227725
Filed on 2024-10-29

GENETICALLY ENGINEERED CELLS, THEIR USES, AND METHODS OF MAKING SAME

Read more about GENETICALLY ENGINEERED CELLS, THEIR USES, AND METHODS OF MAKING SAME

European Patent
23725347.1
Filed on 2024-11-19

PATH2SPACE: AN AI APPROACH FOR CANCER BIOMARKER DISCOVERY VIA HISTOPATHOLOGY INFERRED SPATIAL TRANSCRIPTOMICS

Read more about PATH2SPACE: AN AI APPROACH FOR CANCER BIOMARKER DISCOVERY VIA HISTOPATHOLOGY INFERRED SPATIAL TRANSCRIPTOMICS

US Application 63/703,060
Filed on 2024-10-03

COMPOUNDS FOR ACTIVATING MUCOSAL-ASSOCIATED INVARIANT T CELLS

Read more about COMPOUNDS FOR ACTIVATING MUCOSAL-ASSOCIATED INVARIANT T CELLS

US Application 63/696,421
Filed on 2024-09-19

T CELL RECEPTORS RECOGNIZING MUTATED P53

Read more about T CELL RECEPTORS RECOGNIZING MUTATED P53

Australia
2024227695
Filed on 2024-10-28

T CELL RECEPTORS WHICH RECOGNIZE MUTATED EGFR

Read more about T CELL RECEPTORS WHICH RECOGNIZE MUTATED EGFR

Australia
2024219754
Filed on 2024-09-16

COMPOSITIONS TARGETING GPC2 AND GPC3 AND THEIR USE FOR TREATING SOLID TUMORS

Read more about COMPOSITIONS TARGETING GPC2 AND GPC3 AND THEIR USE FOR TREATING SOLID TUMORS

European Patent
23727442.8
Filed on 2024-11-04

T CELL RECEPTORS RECOGNIZING MUTATED P53

Read more about T CELL RECEPTORS RECOGNIZING MUTATED P53

Japan
2024-178808
Filed on 2024-10-11

METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION

Read more about METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION

European Patent
24215129.8
Filed on 2024-11-25

Subscribe to NCI